StockData
Rezolute, Inc. logo

Rezolute, Inc. (RZLT) stock

RZLTNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$4.01+0.43 (+12.15%)

Close on Nov 17, 2026Market cap $388.34MP/E –Yield –

Rezolute enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Rezolute's enterprise value was $284.57M on Nov 11, 2026, against $732.68M a year earlier. Over the last 5 years it ranged from -$93.66M to $732.68M, with a median of $79.01M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$284.57M+354.2%
2025Dec 31, 2025$62.65M-61.6%
2024Dec 31, 2024$163.16M–
2023Dec 29, 2023-$62.18M–
2022Dec 30, 2022-$78.09M-2048.7%
2021Dec 31, 2021$4.01M-93.7%
2020Dec 31, 2020$63.94M–
2019Dec 31, 2019-$22.07M–
2018Dec 31, 2018-$11.57M-126.6%
2017Dec 29, 2017$43.53M+27.3%
2016Dec 30, 2016$34.19M+3.1%
2015Dec 31, 2015$33.18M+79.6%
2014Dec 31, 2014$18.47M-85.5%
2013Dec 31, 2013$127.20M–

More Rezolute figures

See a number that looks wrong?